Pharmaceutical and Life Sciences

Rx Marketplace Quarterly: Q1 2017

The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry. In each issue we also discuss the most recent quarters' industry IPO's, venture capital funding and M&A activity.

"The Trump administration has focused on various aspects of the PLS industry, including plans to lower drug prices, speed up the FDA approval process, and bring manufacturing back to the US."

Karen C. Young, US pharmaceuticals and life sciences assurance leader

Included in this edition of Rx Marketplace Quarterly:

  • We provide the most recent news related to the new revenue standard and considerations related to other new standards effective for the first quarter of 2017.
  • On the regulatory front, we have provided key reminders on the SEC’s definition of a business.
  • A spotlight section focusing on cybersecurity and why the traditional approaches for protecting an organization may not be sufficient.

Contact us

Laura Robinette
US Pharmaceutical and life sciences Assurance Leader
Tel: +1 (919) 791 4100

Contact us

Kelly Barnes
US health industries leader
Tel: +1 (214) 754 5172

Follow us